Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30517% above fair value
$61.99−1.66 (-2.61%)
Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –
Eton Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Eton Pharmaceuticals's pe ratio was 175.4× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 175.4× | +85.4 |
| 2024 | Jul 31, 2024 | 90.0× | +46.2 |
| 2023 | Dec 29, 2023 | 43.8× | – |
See a number that looks wrong?